Emerging roles of long non-coding RNAs in breast cancer biology and management

I. Amelio, F. Bernassola, E. Candi

Research output: Contribution to journalReview articlepeer-review


Breast cancer is the most common cancer in women with the highest mortality among this gender. Despite treatment strategies including surgery, hormone therapy and targeted therapy have recently advanced, innovative biomarkers are needed for the early detection, treatment and prognosis. An increasing number of non-coding RNAs (ncRNAs) have shown great potential as crucial players in different stages of the breast cancer tumorigenesis, influencing cell death, metabolism, epithelial-mesenchymal transition (EMT), metastasis and drug resistance. Long non-coding RNAs (lncRNAs), specifically, are a class of RNA transcripts with a length greater than 200 nucleotides, which have also been shown to exerts oncogenic or tumour suppressive roles in the pathogenesis of breast cancer. LncRNAs are implicated in different molecular mechanisms by regulating gene expressions and functions at transcriptional, translational, and post-translational levels. Here, we aim to briefly discuss the latest existing body of knowledge regarding the key functions and the molecular mechanisms of some of the most relevant lncRNAs in the pathogenesis, treatment and prognosis of breast cancer.

Original languageEnglish
Pages (from-to)S1044-579X(20)30155-3.
JournalSeminars in Cancer Biology
Publication statusPublished - Jun 30 2020


  • Breast cancer
  • Drug resistance
  • Genomic instability
  • Long non-coding RNA
  • Metastasis
  • Tumour microenvironment

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Emerging roles of long non-coding RNAs in breast cancer biology and management'. Together they form a unique fingerprint.

Cite this